We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBN icon
3026
Northeast Bank
NBN
$1.14B
$50K ﹤0.01%
1,686
+675
+67% +$19.4K
OSS icon
3027
One Stop Systems
OSS
$315M
$50K ﹤0.01%
8,680
-37,210
-81% -$210K
URGN icon
3028
UroGen Pharma
URGN
$2.26B
$50K ﹤0.01%
3,294
-1,256
-28% -$22.7K
UVSP icon
3029
Univest Financial
UVSP
$1.16B
$50K ﹤0.01%
1,881
+684
+57% +$19.2K
VREX icon
3030
Varex Imaging
VREX
$778M
$50K ﹤0.01%
1,847
-2,232
-55% -$54.7K
TFFP
3031
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$50K ﹤0.01%
211
+175
+486% +$48K
AUVI
3032
DELISTED
Applied UV, Inc. Common Stock
AUVI
$50K ﹤0.01%
+41
New +$47.4K
APPH
3033
DELISTED
AppHarvest, Inc. Common Stock
APPH
$50K ﹤0.01%
+3,153
New +$50.3K
QTNT
3034
DELISTED
Quotient Limited Ordinary Shares
QTNT
$50K ﹤0.01%
344
-663
-66% -$106K
OZON
3035
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$50K ﹤0.01%
852
-4,321
-84% -$251K
CPNG icon
3036
Coupang
CPNG
$29.1B
$49K ﹤0.01%
1,174
+243
+26% +$9.95K
CSGS
3037
DELISTED
CSG Systems International
CSGS
$49K ﹤0.01%
1,052
-2,393
-69% -$109K
ECH icon
3038
iShares MSCI Chile ETF
ECH
$1.05B
$49K ﹤0.01%
1,689
+77
+5% +$2.42K
ENB icon
3039
Enbridge
ENB
$112B
$49K ﹤0.01%
1,223
-15,590
-93% -$603K
HOFV
3040
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$49K ﹤0.01%
568
+115
+25% +$9.95K
KALA icon
3041
KALA BIO
KALA
$14.6M
$49K ﹤0.01%
4
+3
+300% +$47.2K
NATR icon
3042
Nature's Sunshine
NATR
$277M
$49K ﹤0.01%
2,821
+2,153
+322% +$42.5K
OM icon
3043
Outset Medical
OM
$92.7M
$49K ﹤0.01%
66
-19
-22% -$14.5K
PLMR icon
3044
Palomar
PLMR
$3.46B
$49K ﹤0.01%
655
-6,772
-91% -$488K
PUK icon
3045
Prudential
PUK
$35.1B
$49K ﹤0.01%
+1,349
New +$55.2K
RNAC icon
3046
Cartesian Therapeutics
RNAC
$265M
$49K ﹤0.01%
391
-145
-27% -$17.3K
SLRC icon
3047
SLR Investment Corp
SLRC
$708M
$49K ﹤0.01%
2,661
+487
+22% +$9.13K
STXS icon
3048
Stereotaxis
STXS
$143M
$49K ﹤0.01%
5,104
+3,204
+169% +$25.3K
OSG
3049
Octave Specialty Group
OSG
$210M
$48K ﹤0.01%
3,024
-305
-9% -$4.9K
FBNC icon
3050
First Bancorp
FBNC
$2.68B
$48K ﹤0.01%
1,170
-563
-32% -$24.3K
120 121
122
123 124

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.